Trials / Sponsors / Artielle ImmunoTherapeutics
Artielle ImmunoTherapeutics
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting | Phase 1 | 2006-12-01 |